Lara Mannelli

413 total citations
14 papers, 123 citations indexed

About

Lara Mannelli is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Lara Mannelli has authored 14 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Lara Mannelli's work include Lymphoma Diagnosis and Treatment (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Lara Mannelli is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Lara Mannelli collaborates with scholars based in Italy, United States and Germany. Lara Mannelli's co-authors include Paola Guglielmelli, Alessandro M. Vannucchi, Giada Rotunno, Giacomo Coltro, Niccolò Bartalucci, Ayalew Tefferi, Emanuela Sant’Antonio, Carmela Mannarelli, Mrinal M. Patnaik and Tiziano Barbui and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Gastroenterology and Hepatology.

In The Last Decade

Lara Mannelli

12 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara Mannelli Italy 5 105 80 59 40 16 14 123
Miklós Egyed Hungary 7 156 1.5× 100 1.3× 94 1.6× 51 1.3× 25 1.6× 23 171
Eveline S. de Bont Netherlands 5 47 0.4× 72 0.9× 36 0.6× 36 0.9× 8 0.5× 16 117
Orlando Antelope United States 6 49 0.5× 72 0.9× 29 0.5× 21 0.5× 8 0.5× 8 105
Stefano Ulisciani Italy 4 45 0.4× 71 0.9× 40 0.7× 28 0.7× 13 0.8× 6 96
Benedetta Sordi Italy 4 140 1.3× 118 1.5× 78 1.3× 54 1.4× 10 0.6× 9 169
Jocelin Huang United States 8 200 1.9× 171 2.1× 104 1.8× 73 1.8× 14 0.9× 13 226
Lucy Pemberton United Kingdom 3 70 0.7× 83 1.0× 12 0.2× 34 0.8× 10 0.6× 7 97
Vasily Shuvaev Russia 8 211 2.0× 232 2.9× 40 0.7× 104 2.6× 16 1.0× 54 255
Alison Callaway United Kingdom 3 47 0.4× 40 0.5× 70 1.2× 18 0.5× 13 0.8× 8 129
Viktor Rossiev Russia 5 57 0.5× 39 0.5× 28 0.5× 36 0.9× 7 0.4× 12 74

Countries citing papers authored by Lara Mannelli

Since Specialization
Citations

This map shows the geographic impact of Lara Mannelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Mannelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Mannelli more than expected).

Fields of papers citing papers by Lara Mannelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Mannelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Mannelli. The network helps show where Lara Mannelli may publish in the future.

Co-authorship network of co-authors of Lara Mannelli

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Mannelli. A scholar is included among the top collaborators of Lara Mannelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Mannelli. Lara Mannelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Cencini, Emanuele, Ilaria Romano, Lara Mannelli, et al.. (2023). Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network). Annals of Hematology. 102(4). 841–849. 1 indexed citations
2.
Cencini, Emanuele, Benedetta Puccini, Federico Simonetti, et al.. (2022). Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network). European Journal Of Haematology. 108(5). 383–390. 1 indexed citations
3.
Skrypets, Tetiana, Cristina Ferrari, Luca Nassi, et al.. (2021). 18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis. Journal of Personalized Medicine. 11(2). 123–123. 2 indexed citations
4.
Romano, Ilaria, Benedetta Puccini, Giacomo Coltro, et al.. (2021). Serum TARC Concentration Kinetic in Classical Hodgkin Lymphoma during First-Line Treatment. Blood. 138(Supplement 1). 4500–4500.
5.
Loscocco, Giuseppe Gaetano, Francesco Mannelli, Lara Mannelli, et al.. (2020). A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease. American Journal of Hematology. 95(12). 1622–1624.
6.
Guglielmelli, Paola, Alessandra Carobbio, Elisa Rumi, et al.. (2020). Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood Cancer Journal. 10(2). 21–21. 40 indexed citations
7.
Coltro, Giacomo, Giada Rotunno, Lara Mannelli, et al.. (2020). RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features. Blood Advances. 4(15). 3677–3687. 52 indexed citations
8.
Mannelli, Lara, Elisabetta Antonioli, Benedetta Puccini, et al.. (2020). Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation. SHILAP Revista de lepidopterología. 2020. 1–6. 1 indexed citations
9.
Mannelli, Lara, Paola Guglielmelli, & Alessandro M. Vannucchi. (2020). Stem cell transplant for the treatment of myelofibrosis. Expert Review of Hematology. 13(4). 363–374. 6 indexed citations
10.
Rigacci, Luigi, Benedetta Puccini, Alessandro Broccoli, et al.. (2019). Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study. Annals of Hematology. 99(2). 283–291. 3 indexed citations
11.
Guglielmelli, Paola, Niccolò Bartalucci, Elisa Contini, et al.. (2019). Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs). Blood. 134(Supplement_1). 2968–2968. 4 indexed citations
12.
Rigacci, Luigi, Sofya Kovalchuk, Valentina Berti, et al.. (2018). The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas. SHILAP Revista de lepidopterología. 17(3). 157–165. 2 indexed citations
13.
Laino, Maria Elena, Monica Ragucci, Ds Klimstra, & Lara Mannelli. (2018). Hepatobiliary and Pancreatic: Primary acinar cell carcinoma of the liver showing good response to chemotherapy. Journal of Gastroenterology and Hepatology. 33(5). 977–977. 2 indexed citations
14.
Cencini, Emanuele, Benedetta Puccini, Luigi Rigacci, et al.. (2017). Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma. Leukemia & lymphoma. 59(6). 1420–1426. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026